Canlyniadau Chwilio - Amber Chevalier

Personalized ctDNA detection and genomic profiling in the NeoRHEA Study gan Alexandra Stanciu, Elisa Agostinetto, Andreas Papagiannis, Christodoulos Pipinikas, Amber Chevalier, Nathan Campbell, Mariana Brandão, Lieveke Ameye, Marianne Paesmans, Tatiana Besse, Francoise Rothe, Laurence Buisseret, Donatienne Taylor, Patrick Neven, Christos Sotiriou, Francois P. Duhoux, Peter Vuylsteke, Michail Ignatiadis

Cael y testun llawn

Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer gan Daniel A. Ruiz-Torres, Ross D. Merkin, Michael E. Bryan, Julia Mendel, Vasileios Efthymiou, Thomas Roberts, Manisha J. Patel, Jong C. Park, Amber Chevalier, Clodagh Murray, Lisa Gates, Christodoulos Pipinikas, Shannon L. Stott, Adam S. Fisch, Lori J. Wirth, Daniel L. Faden

Cael y testun llawn

Monitoring of circulating tumor DNA in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy gan Luc Cabel, Julia Ah-Reum An, Hong-Kyu Kim, Jisun Kim, Christopher Gareth Smith, Amber Chevalier, Tatiana Erazo, Enrico Moiso, Emanuela Ferraro, Anton Safonov, Konner Nelson, Kathleen Szuhany, Joshua Z. Drago, Larry Norton, Amy Xu, Atif J. Khan, Bob T. Li, Mark E. Robson, Sarat Chandarlapaty, George Plitas, Pedram Razavi

Cael y testun llawn

Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy gan Jesús Fuentes-Antrás, Mitchell J. Elliott, Sasha C. Main, Philippe Echelard, Aaron Dou, Philippe L. Bedard, Eitan Amir, Michelle B. Nadler, Nicholas Meti, Nancy Gregorio, Elizabeth Shah, Emily Van de Laar, Celeste Yu, Yangqing Deng, Lisa Gates, Clodagh Murray, Christopher G. Smith, Amber Chevalier, Scott V. Bratman, Lillian L. Siu, Hal K. Berman, David W. Cescon

Cael y testun llawn